Orgenesis to participate in Benchmark’s third Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023

Germantown, Maryland, US, May 19, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, today announced that Vered Caplan, CEO of Orgenesis, will be participating in the Benchmark Company’s third Annual Healthcare House Call Virtual 1x1 Conference, which will be held on Tuesday, May 23, 2023.

The conference offers its clients one-on-one and small-group virtual meetings with the management of over 40 small and mid-sized healthcare companies.  

To register, please contact: Michael Fiorini – Director, Institutional Equity Sales of The Benchmark Company at mfiorini@benchmarkcompany.com or your Benchmark Company representative.

About The Benchmark Company

The Benchmark Company is an investment banking firm offering a suite of corporate finance, advisory and institutional brokerage services. We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research and developing institutional sponsorship by leveraging the firm’s sales, trading and equity research capabilities. https://www.benchmarkcompany.com.

About Orgenesis

Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. www.orgenesis.com.